Juno Bio raised $3.8M to advance products in vaginal health, with support from Ada Ventures, Artesian, Entrepreneur First, and the Illumina Accelerator. The round signals continued investor appetite for women’s health and microbiome-adjacent opportunities, especially where clinical differentiation and diagnostics/product platform strategies can be executed with moderate early capital. Company leadership changes and product plans will be key next steps as the funding supports pipeline development and commercialization readiness.